"Affiliata italiana di Merck KGaA, azienda impegnata nell’innovazione scientifica e tecnologica operante nei settori Healthcare, Life Science ed Electronics. In ambito Healthcare, l'azienda scopre, sviluppa, produce e commercializza farmaci per patologie severe come la sclerosi multipla, i tumori, i disturbi della crescita e della tiroide, le malattie cardiovascolari e l'infertilità. . Italian affiliate of Merck KGaA, a company committed to scientific and technological innovation operating in the Healthcare, Life Science and Electronics sectors. In Healthcare, the company discovers, develops, manufactures and markets drugs for severe diseases: multiple sclerosis, cancer, growth and thyroid disorders, cardiovascular diseases and infertility."

During the past decade, Merck Serono S.p.A. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Merck Serono S.p.A." #1 collaborator was "Merck Serono S.P.A., Italy" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Merck Serono S.p.A." are "Infant, Small for Gestational Age" (1 trials) and "Reproductive Techniques, Assisted" (1 trials). Many other conditions were trialed in "Merck Serono S.p.A." in a lesser frequency.

Most popular intervention types in "Merck Serono S.p.A." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Recombinant human Follicle Stimulating Hormone (r-hFSH) and Recombinant human Luteinizing Hormone (r-hLH)" (1 trials), "Recombinant human growth hormone (r-hGH)" (1 trials) and "r-hFSH" (1 trials). Other intervention names were less common.

The vast majority of trials in "Merck Serono S.p.A." are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Merck Serono S.p.A.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Merck Serono S.p.A., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Merck Serono S.p.A., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".